# Conversation: Research fibroepithelioma risks
Voice: sivah
Created: 2025-10-07T07:50:47.850469

## Human
Research fibroepithelioma of pinkus and determine whether there are any associated risk factors with having had a diagnosis. 

## Sivah
To help with the research, could you clarify whether you're looking for risk factors associated with *developing* fibroepithelioma of Pinkus (FEP), or if you're asking whether having been diagnosed with FEP increases the risk for other conditions, such as additional skin cancers or systemic diseases?

## Human
whether having been diagnosed with FEP increases the risk for other conditions

## Sivah
{
  "task_violates_safety_guidelines": false,
  "user_def_doesnt_want_research": false,
  "response": "Got it. I’ll look into whether a diagnosis of fibroepithelioma of Pinkus (FEP) is associated with an increased risk of other conditions, such as other skin cancers or systemic diseases.\nI'll get back to you with what I find.",
  "title": "Risk Factors Associated With Fibroepithelioma of Pinkus Diagnosis",
  "prompt": "Investigate whether being diagnosed with fibroepithelioma of Pinkus (FEP) is associated with an increased risk of developing other conditions. Specifically, look for any studies, case reports, or medical literature that link FEP with increased incidence of other skin cancers (e.g., basal cell carcinoma, squamous cell carcinoma, melanoma), internal malignancies, genetic syndromes, or systemic diseases. Highlight any statistically significant associations and summarize findings from authoritative dermatological or oncological sources. Present the findings in a clear format, including citations to the original research where possible."
}

## Sivah
Got it. I’ll look into whether a diagnosis of fibroepithelioma of Pinkus (FEP) is associated with an increased risk of other conditions, such as other skin cancers or systemic diseases.
I'll get back to you with what I find.

## Sivah
# Fibroepithelioma of Pinkus (FEP) – Associated Risks and Comorbidities

## Overview of Fibroepithelioma of Pinkus  
Fibroepithelioma of Pinkus (FEP), also known as Pinkus tumor, is an uncommon skin neoplasm originally described as a variant of basal cell carcinoma (BCC). It typically presents as a small, firm, flesh-colored papule or plaque, often on the lower trunk (especially the lumbosacral area) in middle-aged to older adults【4†L113-L122】【15†L185-L193】. Histologically, FEP consists of thin, branching strands of basaloid cells extending into a fibrous stroma, consistent with a low-risk BCC subtype【15†L195-L204】. FEP is considered *indolent* – it grows slowly and **metastasis is exceedingly rare**, with an essentially **non-existent metastatic potential**【15†L214-L222】【25†L225-L233】. Complete surgical excision is typically curative, and unlike aggressive skin cancers, FEP has *never been reported to cause patient death*【25†L225-L233】. 

Because FEP is so closely related to basal cell carcinoma, an important question is whether having an FEP signals elevated risk for other cancers or syndromes. Below we summarize current evidence on FEP and its association with other skin cancers, internal malignancies, genetic conditions, and other systemic diseases.

## Association with Other Skin Cancers  
**Basal Cell Carcinoma (BCC):** FEP is now generally regarded as a *variant of BCC*, and it **often co-exists with or occurs in patients who have other BCC lesions**【15†L199-L204】【15†L189-L197】. In some cases, an FEP can even arise adjacent to or in continuity with a traditional nodular BCC, indicating overlapping pathology【15†L199-L204】. Clinically, patients with a history of BCC appear more likely to develop an FEP than those without such history【15†L189-L197】. This suggests that whatever underlying risk factors (e.g. genetic predisposition or UV exposure history) led to the first BCC might also contribute to FEP occurrence. Conversely, once a Pinkus tumor is diagnosed, **vigilance for additional BCCs is warranted**, as these patients often develop multiple BCCs over time (a well-documented phenomenon in dermatology)【15†L189-L197】. On the positive side, FEP itself remains a low-grade tumor; it very rarely shows aggressive behavior or progression to a more invasive carcinoma【15†L214-L222】.

**Squamous Cell Carcinoma (SCC) and Melanoma:** There is **no direct evidence that FEP predisposes patients to squamous cell carcinoma or melanoma** beyond the general risk that comes with having one skin cancer. FEP lesions typically arise in sun-protected areas (unlike many SCCs or melanomas), and chronic UV damage is thought to play less of a role in FEP pathogenesis【6†L137-L145】【15†L189-L197】. Therefore, an FEP diagnosis *by itself* has not been linked to higher SCC or melanoma incidence in the literature. That said, patients with any history of skin cancer should practice routine sun protection and skin surveillance. Notably, large epidemiologic studies (not specific to FEP but to BCC survivors) have found that **individuals who have had a BCC carry an elevated risk of developing melanoma** compared to the general population【6†L163-L171】. This is likely due to shared risk factors (fair skin, UV exposure, etc.) rather than any causative role of the FEP lesion. In summary, **FEP does not appear to *cause* other skin malignancies**, but it serves as a marker that the patient’s skin has a tendency to form tumors (especially BCCs), warranting ongoing dermatologic follow-up.

## Internal Malignancies (e.g. Gastrointestinal Cancers)  
**Gastrointestinal (GI) Tumors:** The most debated potential association is between FEP and internal malignancies, particularly gastrointestinal cancers. In 2016, a retrospective study of 49 FEP cases made headlines by reporting that **9 of 49 patients (18%) had an associated gastrointestinal malignancy**, such as colon cancer【4†L115-L123】. In many of those patients, the FEP was diagnosed *before* the internal tumor, prompting speculation that FEP could be a cutaneous marker of an underlying GI cancer【4†L115-L123】. The authors suggested considering **GI cancer screening in patients with FEP**, given this seemingly high co-occurrence rate【4†L115-L123】. However, it’s important to note that this was an observational series without a control group; while 18% is notable, it’s unclear if this exceeded the expected cancer incidence in an older population. No specific genetic mutation or syndrome was identified to link the FEP and GI tumors in that study【4†L117-L122】.

**Follow-up Studies:** More recent research has cast doubt on a causal link between FEP and internal malignancies. A 2023 single-center retrospective study specifically investigated whether having an FEP predicts internal cancers, especially GI tract tumors【5†L302-L310】. **This study found no significant association** – patients with FEP did *not* have higher rates of gastrointestinal cancers than would be expected by chance【5†L302-L310】. The authors concluded that **the presence of an FEP does not warrant any special cancer screenings beyond standard age-appropriate guidelines**【5†L302-L310】. In other words, current evidence suggests that FEP is *likely a coincidental finding* in patients who developed internal cancers, rather than a reliable red flag for hidden malignancy.

**Other Internal Malignancies:** Aside from the GI tract, no strong statistical associations have been documented between FEP and other internal cancers. Earlier anecdotal reports noted isolated cases of FEP occurring in proximity to internal tumors – for example, **an FEP arising in the skin overlying a breast carcinoma**【6†L163-L171】. In a 1985 case, a Pinkus tumor was found directly above a breast cancer in the same breast, raising the question of a field effect or paraneoplastic phenomenon【6†L163-L171】. However, such occurrences are *extremely rare*, and larger studies have not shown any consistent link between FEP and breast or other internal malignancies. Taken together, **authoritative sources indicate that FEP “is not known to result in further complications or malignancy”** on a routine basis【6†L163-L171】. Any associations with internal cancers appear to be uncommon and may represent chance coincidences or special circumstances rather than a general rule.

## Genetic Syndromes and Predispositions  
Because FEP is a type of basal cell carcinoma, it can occur as part of hereditary syndromes that lead to multiple BCCs. **Patients with numerous, early-onset, or unusually distributed FEP lesions should be evaluated for an underlying genetic syndrome**【15†L221-L229】. Known syndromes associated with FEP (and BCCs in general) include:

- **Gorlin Syndrome (Nevoid Basal Cell Carcinoma Syndrome):** An autosomal dominant condition (due to PTCH1 gene mutations) characterized by hundreds of BCCs from a young age, jaw cysts, palmoplantar pits, and skeletal abnormalities. Gorlin syndrome patients can develop FEPs among their many BCCs【15†L221-L229】. In fact, any young patient with a Pinkus tumor should raise suspicion for Gorlin syndrome or a similar genetic predisposition, since sporadic FEP is rare in youth【15†L221-L229】.

- **Bazex-Dupré-Christol Syndrome:** A rare X-linked dominant disorder featuring **multiple BCCs (including FEP)**, follicular atrophoderma (pit-like depressions on the skin), hypotrichosis (sparse hair), and milia. Bazex syndrome typically presents BCCs early in life. FEPs have occasionally been noted in these patients as one variant of their basal cell carcinomas【15†L221-L229】.

- **Rombo Syndrome:** An extremely rare genodermatosis involving vermiculate atrophoderma (a texture change of facial skin), telangiectasias, acral erythema, and development of multiple BCCs in adulthood. FEP lesions can be part of the BCC spectrum seen in Rombo syndrome【15†L221-L229】. 

It’s important to emphasize that **outside of these syndromic contexts, FEP usually occurs as an isolated sporadic tumor**. Most patients diagnosed with a solitary FEP do not have a hereditary syndrome. However, the presence of **multiple FEP lesions, or FEP at a very young age, is a red flag for an inherited BCC syndrome** and should prompt genetic evaluation【15†L221-L229】. In summary, while **no unique “FEP-only” syndrome exists, FEP can be one manifestation of the known BCC-predisposition syndromes** listed above.

## Other Reported Associations and Systemic Considerations  
Beyond the major categories above, the medical literature contains a few *case reports* of FEP occurring alongside other conditions. These isolated reports do not necessarily imply causation but are worth noting:

- **Overlap with Paget Disease:** One report described *fibroepithelioma-like changes* arising within an area of **extramammary Paget disease** (a rare skin cancer of sweat gland origin) in the perianal region, which was associated with an underlying rectal adenocarcinoma【6†L163-L171】. In that case, the FEP-like lesion was essentially part of a complex presentation of Paget disease and internal malignancy. This is exceedingly uncommon and represents a histologic curiosity more than a predictable risk for FEP patients in general.

- **Radiation Exposure:** Though not a “condition” per se, prior **radiation therapy to the skin** has occasionally been linked to the development of FEP. Several published cases document FEP arising in areas previously irradiated (for example, for other cancers or dermatologic conditions)【15†L220-L227】. Chronic radiation damage might create a field effect favoring indolent tumor development. This association is rare and the exact contribution of radiation to FEP formation remains unclear【15†L220-L227】.

- **Immunosuppression:** There is currently no robust evidence tying FEP to systemic immunosuppression (such as in organ transplant recipients or HIV patients). Immunosuppressed individuals do get more skin cancers in general, but FEP is so rare that no pattern has been established. Most reported FEP cases have been in immunocompetent patients.

In conclusion, **fibroepithelioma of Pinkus is primarily a localized skin issue and does not usually signal broader health problems**. It is best viewed as a low-grade variant of basal cell carcinoma. **The consensus in dermatology and oncology literature is that FEP itself has minimal aggressive potential and is not a prognostic marker for internal disease**【6†L163-L171】【5†L302-L310】. While a few studies and case reports have noted associations with other malignancies (especially GI tumors in one series)【4†L115-L123】, these findings are not yet confirmed by larger data and have been challenged by subsequent research【5†L302-L310】. Similarly, apart from known genetic syndromes that predispose to all forms of BCC, having an FEP does not imply the patient has an inherited cancer syndrome. The key takeaways for clinicians are to **manage FEP with proper excision and follow up** as one would for any BCC, **remain alert for additional skin cancers** (since patients can develop new BCCs or other UV-related cancers over time), and **consider age-appropriate screenings** for internal cancers as usual, rather than ordering any special tests solely on the basis of an FEP diagnosis【5†L302-L310】.

## References

- Haddock ES & Cohen PR. *Fibroepithelioma of Pinkus revisited*. **Dermatol Ther (Heidelb)**. 2016;6(3):347–362. PMID: 27311952.  
- Longo C *et al.* *Fibroepithelioma of Pinkus: Solitary tumor or sign of a complex gastrointestinal syndrome*. **Mol Clin Oncol**. 2016;4(5):797–800【4†L115-L123】.  
- Kim JB *et al.* *Dissociating Fibroepithelioma of Pinkus From Internal Malignancy: A Single-Center Retrospective Study*. **Cutis**. 2023;111(1):E26–E30【5†L302-L310】.  
- DermNet NZ. *Fibroepithelioma of Pinkus*. Updated Feb 2019. (Author: B. Law; Editor: A. Oakley)【6†L163-L171】.  
- Reggiani C *et al.* *Fibroepithelioma of Pinkus: case reports and review of the literature*. **Dermatology**. 2013;226(3):207–211. PMID: 23711617.  
- Moye V & Stern RS. *Basal Cell Carcinoma as a Marker of Risk for Subsequent Malignancies*. **J Invest Dermatol**. 2019;139(12):2474–2476. (Discussing melanoma risk after BCC).  
- Mazzarella F *et al.* *Fibroepithelioma of Pinkus masquerading as a widely distributed papulosquamous disease*. **J Dermatol Derm Surg**. 2019;23(1):32–34【15†L221-L229】【15†L189-L197】.  
- Bryant J. *Fibroepithelioma of Pinkus overlying breast cancer*. **Arch Dermatol**. 1985;121(3):310【6†L163-L171】.  
- Ishida-Yamamoto A *et al.* *Fibroepithelioma-like changes in perianal Paget disease with rectal carcinoma*. **J Cutan Pathol**. 2002;29(3):185–189【6†L163-L171】.